abstract |
The present invention relates to compounds of Formula (I), a process for the manufacture thereof, their use for the preparation of medicaments for treating CNS disorders and pharmaceutical compositions containing them. Compounds of Formula (I) are represented by general Formula (I) wherein R1, R2 , R3 and R4 are defined as in the specification. |